Jean Emond

1.8k total citations
27 papers, 1.3k citations indexed

About

Jean Emond is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Jean Emond has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in Jean Emond's work include Prostate Cancer Treatment and Research (24 papers), Hormonal and reproductive studies (14 papers) and Prostate Cancer Diagnosis and Treatment (13 papers). Jean Emond is often cited by papers focused on Prostate Cancer Treatment and Research (24 papers), Hormonal and reproductive studies (14 papers) and Prostate Cancer Diagnosis and Treatment (13 papers). Jean Emond collaborates with scholars based in Canada, Germany and France. Jean Emond's co-authors include Fernand Labrie, G. Monfette, A. Dupont, A. Bèlanger, Yves Lacourcière, M. Giguère, Raul Suburu, André Dupont, J.M. Husson and A.T.A. Fazekas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Endocrine Reviews and The Journal of Urology.

In The Last Decade

Jean Emond

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Emond Canada 14 1.0k 516 196 168 161 27 1.3k
Bo‐Eric Persson Denmark 18 1.4k 1.4× 856 1.7× 219 1.1× 271 1.6× 170 1.1× 47 1.8k
G. Monfette Canada 10 673 0.7× 472 0.9× 154 0.8× 150 0.9× 91 0.6× 17 886
A Dupont Canada 10 457 0.4× 340 0.7× 145 0.7× 124 0.7× 62 0.4× 26 695
S.-O. Andersson Sweden 10 794 0.8× 463 0.9× 578 2.9× 125 0.7× 390 2.4× 12 1.5k
M K Brawer United States 21 811 0.8× 92 0.2× 226 1.2× 44 0.3× 124 0.8× 36 1.1k
Tony T. Wu Taiwan 15 542 0.5× 135 0.3× 382 1.9× 91 0.5× 327 2.0× 32 1.1k
John E. McNeal United States 8 465 0.5× 95 0.2× 178 0.9× 256 1.5× 93 0.6× 9 671
Masaki Shimbo Japan 14 484 0.5× 169 0.3× 162 0.8× 46 0.3× 113 0.7× 51 672
CJ Tyrrell United Kingdom 12 478 0.5× 254 0.5× 70 0.4× 67 0.4× 168 1.0× 17 682
C. Avancès France 14 305 0.3× 115 0.2× 449 2.3× 83 0.5× 134 0.8× 46 1.0k

Countries citing papers authored by Jean Emond

Since Specialization
Citations

This map shows the geographic impact of Jean Emond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Emond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Emond more than expected).

Fields of papers citing papers by Jean Emond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Emond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Emond. The network helps show where Jean Emond may publish in the future.

Co-authorship network of co-authors of Jean Emond

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Emond. A scholar is included among the top collaborators of Jean Emond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Emond. Jean Emond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emond, Jean, et al.. (2010). Surface ice observations on the St. Lawrence River using infrared thermography. River Research and Applications. 27(9). 1090–1105. 9 indexed citations
2.
Emond, Jean, et al.. (2005). VAPOR PRESSURE DEFICIT AND WATER LOSS PATTERNS DURING SIMULATED AIR SHIPMENT AND STORAGE OF BEIT ALPHA CUCUMBERS. Acta Horticulturae. 1697–1704. 5 indexed citations
3.
Dupont, A., L. Cusan, Michael Koutsilieris, et al.. (1993). Combination Therapy with Flutamide and the LHRH Agonist [D‐Trp 6 , des‐Gly‐NH 2 10 ]LHRH Ethylamide in Stage C Prostatic Carcinoma. British Journal of Urology. 72(5). 629–634. 16 indexed citations
4.
Labrie, Fernand, Raul Suburu, L. Cusan, et al.. (1993). Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.. PubMed. 16(6). 425–39. 34 indexed citations
5.
Dupont, A., Fernand Labrie, L. Cusan, et al.. (1992). Combination Therapy with Flutamide and Castration (Orchiectomy or LH-RH Agonist) in Untreated Patients with Advanced Prostate Cancer. Recent results in cancer research. 124. 43–54. 1 indexed citations
6.
Labrie, Fernand, A. Dupont, L. Cusan, et al.. (1990). Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 943–950. 12 indexed citations
7.
Labrie, Fernand, A. Dupont, A. Bèlanger, et al.. (1989). Anti‐hormone Treatment for Prostate Cancer Relapsing after Treatment with Flutamide and Castration. British Journal of Urology. 63(6). 634–638. 21 indexed citations
8.
Labrie, Fernand, André Dupont, L. Cusan, et al.. (1989). Combination therapy with castration and flutamide: Today's treatment of choice for prostate cancer. Journal of Steroid Biochemistry. 33(4). 817–821. 9 indexed citations
9.
Labrie, Fernand, A. Dupont, M. Giguère, et al.. (1988). Benefits of Combination Therapy with Flutamide in Patients Relapsing after Castration. British Journal of Urology. 61(4). 341–346. 50 indexed citations
10.
Labrie, Fernand, André Dupont, L. Cusan, et al.. (1988). Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: Today's therapy of choice. Journal of Steroid Biochemistry. 30(1-6). 107–117. 19 indexed citations
11.
Dupont, André, Fernand Labrie, Yves Lacourcière, et al.. (1988). Combination therapy with flutamide and [d-Trp6]LHRH ethylamide for stage C prostatic carcinoma. European Journal of Cancer and Clinical Oncology. 24(4). 659–666. 12 indexed citations
12.
Labrie, Fernand, M. Giguère, Yves Lacourcière, et al.. (1988). Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.. PubMed. 260. 41–62. 6 indexed citations
13.
Labrie, Fernand, André Dupont, L. Cusan, et al.. (1988). Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma. European Journal of Cancer and Clinical Oncology. 24(12). 1869–1878. 11 indexed citations
14.
Labrie, Fernand, L. Cusan, Isabel A Lüthy, et al.. (1987). Combination therapy in stage C and D prostatic cancer: rationale and five-year clinical experience. Cancer and Metastasis Reviews. 6(4). 615–636. 4 indexed citations
15.
Labrie, Fernand, A. Dupont, M. Giguère, et al.. (1987). Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients. Journal of Steroid Biochemistry. 27(1-3). 525–532. 16 indexed citations
16.
Labrie, Fernand, A. Dupont, M. Giguère, et al.. (1986). Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer. Journal of Steroid Biochemistry. 25(5). 877–883. 14 indexed citations
17.
Labrie, Fernand, A Dupont, A. Bèlanger, et al.. (1986). Treatment of Prostate Cancer with Gonadotropin-Releasing Hormone Agonists. Endocrine Reviews. 7(1). 67–74. 141 indexed citations
18.
Labrie, Fernand, A. Bèlanger, Y. Lacoursière, et al.. (1985). Antiandrogènes et agonistes de LHRH dans le traitement du cancer de la prostate. médecine/sciences. 1(8). 435–435. 1 indexed citations
19.
Labrie, Fernand, A. Dupont, A. Bélanger, Jean Emond, & G. Monfette. (1984). Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.. Proceedings of the National Academy of Sciences. 81(12). 3861–3863. 45 indexed citations
20.
Labrie, Fernand, A. Dupont, A. Bèlanger, et al.. (1982). New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.. PubMed. 5(4). 267–75. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bo‐Eric Persson Breakdown of academic impact, for papers by G. Monfette Breakdown of academic impact, for papers by A Dupont Breakdown of academic impact, for papers by S.-O. Andersson Breakdown of academic impact, for papers by M K Brawer Breakdown of academic impact, for papers by Tony T. Wu Breakdown of academic impact, for papers by John E. McNeal Breakdown of academic impact, for papers by Masaki Shimbo Breakdown of academic impact, for papers by CJ Tyrrell Breakdown of academic impact, for papers by C. Avancès
Rankless by CCL
2026